Lessons learned in the collection of convalescent plasma during the COVID‐19 pandemic

BACKGROUND: The lack of definitive treatment or preventative options for COVID‐19 led many clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic. Regulators, blood centres and hospitals worldwide worked quickly to get CCP to the bedside. Although response was admirable...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vox Sang
Autors principals: Wendel, Silvano, Land, Kevin, Devine, Dana V., Daly, James, Bazin, Renée, Tiberghien, Pierre, Lee, Cheuk‐Kwong, Arora, Satyam, Patidar, Gopal K., Khillan, Kamini, Smid, Willem Martin, Vrielink, Hans, Oreh, Adaeze, Al‐Riyami, Arwa Z., Hindawi, Salwa, Vermeulen, Marion, Louw, Vernon, Burnouf, Thierry, Bloch, Evan M., Goel, Ruchika, Townsend, Mary, So‐Osman, Cynthia
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250874/
https://ncbi.nlm.nih.gov/pubmed/33772791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vox.13096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars